| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |